Picture of Novakand Pharma AB logo

NOVKAN — Novakand Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Kancera Q2 Operating Loss Widens To SEK 18.3 Million

Aug 18 (Reuters) - Kancera AB  KANC.ST :
    * OPERATING INCOME FOR Q2 AMOUNTED TO SEK -18.3 MILLION (SEK
-15.4
MILLION)

Source text for Eikon:  ID:nMFN5stKgw 
Further company coverage:  KANC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Novakand Pharma AB

See all news